跳至主要内容
临床试验/ACTRN12608000489392
ACTRN12608000489392已完成未知

The Study of Mental Activity and Regular Training for the Prevention of Cognitive Decline in at Risk Individuals: The SMART Trial

niversity of Sydney0 个研究点目标入组 100 人开始时间: 2008年9月30日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
55 Years 至 120 Years(—)
性别
All

入选标准

  • Age 55 or above with a corrected Mini-Mental State Exam score of 29 or below; willing to have multiple cognitive, physical and imaging assessments over 12 months; has a suitable informant (if available) that is willing and able to answer questions about their past and current condition; understands and agrees to comply with random allocation process; has telephone at home. There will be 3-stage screening, which includes: Telephone screen by RA of participant and informant (if available) for willingness to participate, sedentary status, no exclusionary medical history, and TICS < or equal to 30. This will be followed by In-person screen by neuropsychologist and later on by In-person screen by geriatrician/stress testing (to ascertain unstable or unsuitable medical conditions).

排除标准

  • Diagnosis of dementia, more than 1 stroke or transient ischemic attack (TIA) or major degenerative neurological disease; current psychotic illness diagnosis, current/past alcohol or drug abuse; current or past use of prescribed cognitive enhancing medication such as cholinesterase inhibitor, nootropic agents; no competency in English, or unable to read and write or use computers due to sensory impairment; high participation in mental activity; current participation in planned structured exercise of any kind other than low- intensity walking 1 or more days per week; Activities of daily living (ADL) or instrumental activities of daily living (IADL) impairment due to cognition; non-ambulatory; contraindications to high intensity progressive resistance training (PRT) or maximal exercise testing

研究者

相似试验